Drug factory · FDA FEI 2246982
Robertson Microlit Laboratories, Inc.
1705 U.S. Highway 46 Suite 1D, Ledgewood, NJ, United States
No problems found at FDA's last inspection, Jan 11, 2024.
No Action Indicated: inspectors found no objectionable conditions.
5 drug inspections on record since 2010: 4 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Amifampridine | Tests it | Catalyst Pharmaceuticals, Inc. | 69616-211 |
| Dordaviprone | Tests it | Jazz Pharmaceuticals, Inc. | 68727-250 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 11, 2024 | No problems found | Drug Quality Assurance | — |
| Mar 23, 2017 | No problems found | Drug Quality Assurance | — |
| Sep 9, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 20, 2011 | No problems found | Drug Quality Assurance | — |
| Jan 20, 2010 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.